+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years - 99Years
FEMALE
ID05601037

Surgical Lymphovenous Anastomosis to Prevent Breast Cancer-Related Lymphedema in Women Undergoing Axilla Dissection

Led by University Hospital, Ghent · Updated on 2024-11-08

80

Participants Needed

1

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Lymphedema is a long-term condition caused by blockage of lymph flow, often occurring after surgery to lymph nodes in the armpit or groin area. This trial focuses on women with breast cancer who need lymph node removal in the armpit and aims to evaluate whether adding a surgical procedure called lymphovenous anastomosis LVA can help prevent lymphedema. The study is a randomized controlled trial conducted by University Hospital, Ghent to explore this preventive approach. Participants are randomly assigned to one of two groups one group undergoes standard axilla dissection surgery alone, while the other group receives an additional LVA procedure, which creates a bypass between lymphatic vessels and veins. The trial involves 80 patients and follows them for two years to compare outcomes between these groups. During the study, participants will have regular follow-up visits for two years. Researchers will measure arm volume using circumference measurements to assess swelling, aiming to keep swelling under 5%. The study will monitor participants closely to evaluate the prevention of lymphedema after surgery and to ensure participant safety throughout the follow-up period.

CONDITIONS

Brief Title

LymphoVenous Anastomosis to Prevent Breast Cancer Related Lymphedema

Research Team

B

Bernard Depypere, MD

J

Jessie De Kinder

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here